Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in Atypical Teratoid/Rhabdoid Tumors
Preprint in bioRxiv (September 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Preprint in bioRxiv (September 2023)
Article in Molecular and Cellular Biochemistry (July 2023)
Article in Frontiers in Oncology (June 2023)